Sanofi India's MD Rajaram Narayanan steps down to pursue other opportunities

14 Jan 2022 , 01:10 PM

Sanofi India, on Thursday, announced the acceptance of resignation of its Managing Director Rajaram Narayanan w.e.f. close of business hours on April 10, 2022.

Rajaram has decided to work on an opportunity outside the Sanofi Group. The company will appoint its successor in the meantime for smooth functioning of its business, said the company.

Rajaram has had an excellent journey since his joining in 2014 as a general manager until his promotion as Country Lead and Managing Director.

During Rajaram’s tenure in the company, it has accomplished the title of top employer for three consecutive years and has also received various recognitions for its unmatched initiatives in communications, HR practices, corporate social responsibility, and public health.

Aditya Narayan, chairman of the Board, SIL India expressed that, under Rajaram’s leadership Sanofi India has been thriving in terms of growth in key therapies, and has significantly contributed to the improvement of the overall financials of the company.

Sanofi India is now well-placed to make a substantial difference to patients with its enthralled portfolio, digital solutions, and outstanding talents. Sanofi always leaves a trailing impact on people who get associated with it.

Sanofi India Ltd is currently trading at Rs7,565.10 up by Rs30.75 or 0.41% from its previous closing of Rs7,534.35 on the BSE.